
Tirzepatide raised testosterone more than TRT in men with obesity (pilot, n=83)
Louis shares a small controlled pilot study in obese men with metabolic hypogonadism. Two months of tirzepatide gave greater weight loss and increases in testosterone, LH, FSH and SHBG while lowering estradiol, compared with no treatment or transdermal testosterone.









